Nanoco Group - Focusing group resources

Since announcing the termination of the formal sale process in April, Nanoco has reshaped its activities while remaining focused on the commercialisation of its patented nano-material technology. Having defined the scope of the company’s activities, management has reassigned costs to maintain a cash runway to at least the end of calendar year 2022. As part of this programme and in line with the board’s succession planning, CEO Dr Michael Edelman has stepped down. Although our estimates remain under review, we hope to see fresh guidance when the FY20 results are announced in October.